Form 8-K - Current report:
SEC Accession No. 0001104659-24-062575
Filing Date
2024-05-16
Accepted
2024-05-16 16:49:31
Documents
15
Period of Report
2024-05-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2414276d2_8k.htm   iXBRL 8-K 26045
2 EXHIBIT 5.1 tm2414276d2_ex5-1.htm EX-5.1 6934
3 GRAPHIC image_002.jpg GRAPHIC 52816
  Complete submission text file 0001104659-24-062575.txt   281051

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA eyen-20240516.xsd EX-101.SCH 3015
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyen-20240516_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyen-20240516_pre.xml EX-101.PRE 22359
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2414276d2_8k_htm.xml XML 3670
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 24956371
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)